CMS NEWS
FOR IMMEDIATE RELEASE
October 23, 2018
Contact: CMS Media
Relations
(202) 690-6145 | CMS Media Inquiries
CMS model addresses opioid misuse among expectant and new
mothers
Goals are to improve quality of care, increase access to treatment based on state-specific needs, and reduce expenditures
Today the Centers for
Medicare & Medicaid Services (CMS) announced the Maternal Opioid Misuse
(MOM) model, an important step in advancing the agency’s multi-pronged
strategy to combat the nation’s opioid crisis. The model addresses the need
to better align and coordinate care of pregnant and postpartum Medicaid
beneficiaries with opioid use disorder (OUD) through state-driven
transformation of the delivery system surrounding this vulnerable population.
By supporting the coordination of clinical care and the integration of other
services critical for health, wellbeing, and recovery, the MOM model has the
potential to improve quality of care and reduce expenditures for mothers and
infants.
“Too many barriers impede
the delivery of well-coordinated, high-quality care to pregnant and
postpartum women struggling with opioid misuse, including lack of access to
treatment and a shortage of providers in rural areas, where the opioid crisis
is especially destructive,” said HHS Secretary Alex Azar. “The MOM model will
support state Medicaid agencies, front-line providers and healthcare systems
to help ensure that mothers and infants afflicted by the opioid epidemic get the
care they need.”
Substance use-related
illness and death is now a leading cause of maternal death. Pregnant
and postpartum women who misuse substances are at high risk for poor maternal
outcomes, including preterm labor and complications related to delivery;
these problems are frequently exacerbated by malnourishment, interpersonal
violence, and other health-related social needs. Infants exposed to opioids
before birth are at greater risk for negative health outcomes such as higher
risk of being born preterm, having a low birth weight, and experiencing the
effects of neonatal abstinence syndrome (NAS), a group of conditions caused
when an infant withdraws from certain drugs s/he is exposed to in the womb.
In addition, Medicaid pays the largest portion of hospital charges for
maternal substance use, as well as a majority of the $1.5 billion annual cost
of NAS.
The primary goals of the
model are to:
·
Improve
quality of care and reduce expenditures for pregnant and postpartum women
with OUD as well as their infants;
·
Increase
access to treatment, service-delivery capacity, and infrastructure based on
state-specific needs; and
·
Create
sustainable coverage and payment strategies that support ongoing coordination
and integration of care.
The CMS Innovation Center
will execute up to 12 cooperative agreements with states, whose Medicaid
agencies will implement the model with one or more “care-delivery partners”
in their communities. The MOM model will serve pregnant Medicaid and
Children’s Health Insurance Program (CHIP) beneficiaries with OUD who have
elected to participate, during the prenatal, peripartum (i.e., surrounding
labor and delivery), and postpartum periods. Awardees will be responsible for
ensuring that beneficiaries participating in the model have access to a set
of essential physical and behavioral health services, such as
medication-assisted treatment (MAT) for OUD, maternity care, relevant primary
care services, and other mental and behavioral health services beyond
MAT.
The MOM model will have a
five-year period of performance with different types of funding.
Specifically, implementation funding, transition funding, and the opportunity
for milestone funding will be provided in three distinct model periods:
Pre-implementation (Year 1), Transition (Year 2), and Full Implementation
(Years 3-5).
Care delivery will begin
in Year 2, or the Transition Period, of the model. During this year, funding
for care-delivery services that are not otherwise covered by Medicaid will be
provided by Innovation Center funds. By Year 3, the start of the Full
Implementation Period, states must implement coverage and payment strategies.
This overall structure seeks to balance rapid model initiation and state
flexibility, while minimizing administrative burden. In particular, the MOM
model design supports each awardee’s ability to quickly begin delivering
coordinated and integrated care to pregnant and postpartum women with OUD
during the Transition Period, while supporting states in developing a
long-term coverage and payment strategy that aligns with their state Medicaid
program.
CMS anticipates releasing
a Notice of Funding Opportunity (NOFO) in early 2019 to solicit cooperative
agreement applications to implement the MOM model. The state Medicaid agency
will be expected to complete the application, which must demonstrate that it
has partnered with at least one care-delivery partner. A maximum of $64.6
million will be available across up to 12 state awardees over the course of
the five-year model. The NOFO will contain all model requirements and
eligibility criteria for potential applicants.
In August, CMS announced the Integrated Care for Kids (InCK) Model, a
child-centered local service delivery and state payment model aimed at
reducing expenditures and improving the quality of care for children covered
by Medicaid and CHIP through prevention, early identification, and treatment
of priority health concerns like behavioral health challenges, including
substance abuse. The model will empower states and local providers to
better address these needs through care integration across all types of
healthcare providers. CMS anticipates releasing a NOFO for the InCK Model at
the same time as it does for the MOM Model.
For more information,
please visit https://innovation.cms.gov/initiatives/maternal-opioid-misuse-model/ or
the fact sheet: https://www.cms.gov/sites/drupal/files/2018-10/10-23-2018%20Fact%20Sheet%20Maternal%20Opioid%20Misuse%20%28MOM%29%20Model%20%28FINAL%29.pdf
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS
Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.
|
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, October 23, 2018
CMS model addresses opioid misuse among expectant and new mothers
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment